Marshall Wace, LLP Ovid Therapeutics Inc. Transaction History
Marshall Wace, LLP
- $81.7 Billion
- Q2 2025
A detailed history of Marshall Wace, LLP transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 164,721 shares of OVID stock, worth $90,596. This represents 0.0% of its overall portfolio holdings.
Number of Shares
164,721Holding current value
$90,596% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding OVID
# of Institutions
71Shares Held
32.7MCall Options Held
15.6KPut Options Held
0-
Black Rock Inc. New York, NY3.99MShares$2.2 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$2.12 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.64MShares$1.45 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.23MShares$1.23 Million0.35% of portfolio
-
Acadian Asset Management LLC Boston, MA2.11MShares$1.16 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $38.7M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...